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Capturing the diversity of the human gut
microbiota through culture-enriched
molecular profiling
Jennifer T. Lau1, Fiona J. Whelan1, Isiri Herath1, Christine H. Lee2,3, Stephen M. Collins4, Premysl Bercik4
and Michael G. Surette1,4*
Abstract
Background: The human gut microbiota has been implicated in most aspects of health and disease; however,
most of the bacteria in this community are considered unculturable, so studies have relied on molecular-based
methods. These methods generally do not permit the isolation of organisms, which is required to fully explore
the functional roles of bacteria for definitive association with host phenotypes. Using a combination of culture
and 16S rRNA gene sequencing, referred to as culture-enriched molecular profiling, we show that the majority of
the bacteria identified by 16S sequencing of the human gut microbiota can be cultured.
Methods: Five fresh, anaerobic fecal samples were cultured using 33 media and incubation of plates anaerobically and
aerobically resulted in 66 culture conditions for culture-enriched molecular profiling. The cultivable portion of the fecal
microbiota was determined by comparing the operational taxonomic units (OTUs) recovered by 16S sequencing of the
culture plates to OTUs from culture-independent sequencing of the fecal sample. Targeted isolation of Lachnospiraceae
strains using conditions defined by culture-enriched molecular profiling was carried out on two fresh stool samples.
Results: We show that culture-enriched molecular profiling, utilizing 66 culture conditions combined with 16S
rRNA gene sequencing, allowed for the culturing of an average of 95 % of the OTUs present at greater than 0.
1 % abundance in fecal samples. Uncultured OTUs were low abundance in stool. Importantly, comparing
culture-enrichment to culture-independent sequencing revealed that the majority of OTUs were detected only
by culture, highlighting the advantage of culture for studying the diversity of the gut microbiota. Applying
culture-enriched molecular profiling to target Lachnospiraceae strains resulted in the recovery of 79 isolates, 12
of which are on the Human Microbiome Project’s “Most Wanted” list.
Conclusions: We show that, through culture-enriched molecular profiling, the majority of the bacteria in the
human gut microbiota can be cultured and this method revealed greater bacterial diversity compared to
culture-independent sequencing. Additionally, this method could be applied for the targeted recovery of a
specific bacterial group. This approach allows for the isolation of bacteria of interest from the gut microbiota,
providing new opportunities to explore mechanisms of microbiota–host interactions and the diversity of the
human microbiota.
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Background
The gastrointestinal microbiota is a highly diverse com-
munity but the majority of the bacteria are considered
unculturable since more recent sequencing-based stud-
ies have revealed greater diversity than previously de-
tected by culture [1, 2]. Consequently, most studies
characterizing the human gut microbiome have relied on
culture-independent sequencing methods. These studies
have provided insights into the community composition
of the gut microbiota in healthy individuals [3], how it
changes with environmental perturbation [4, 5], and its
potential role in a variety of diseases [6, 7]. However,
there are limitations to the information that can be ob-
tained from molecular approaches alone and the isola-
tion of organisms is required to define the roles of
specific bacteria in causing or maintaining healthy and
disease states. Culture also determines the viable popula-
tion in a community, while most molecular methods do
not distinguish between DNA obtained from live or dead
cells. Furthermore, culture using selective media allows
for the growth and detection of less abundant bacteria
that may be missed by insufficient sequencing depth in
culture-independent studies [8].
A few recent studies have attempted to characterize
the culturable human gut microbiota by combining cul-
ture with next-generation sequencing [9] but only a
maximum of 50 % of the operational taxonomic units
(OTUs) detected by 16S rRNA gene sequencing of fecal
samples were cultivable [10, 11]. Lagier et al. [8] devel-
oped a culturomics method, which used 212 conditions
for the cultivation of the fecal microbiota. However, bac-
terial colonies were identified with MALDI-TOF mass
spectrometry, making it difficult to directly compare to
OTUs obtained from pyrosequencing in order to deter-
mine the culturable proportion of the microbiota [8]. This
study identified 174 novel bacterial species, demonstrating
that culture is still a valuable method for exploring the gut
microbiome. Another study, by Rettedal et al. [11] tested
several culture conditions to capture a representative pro-
portion and maintain the overall community structure of
the gut microbiota. From ten media, 88 % of family level
taxonomic groups were recovered and, interestingly, 40 %
more OTUs were found by culture than by culture-
independent methods, demonstrating the potential advan-
tages of culture for capturing microbial diversity in the
gut. Another study has shown that personalized culture
conditions, although only representing 50 % of the phylo-
types observed from culture-independent sequencing,
could colonize germ-free mice in a similar manner to the
complete fecal samples [10].
In this study, a method of culture-enriched molecular
profiling [12] which combines extensive bacterial cul-
ture with 16S rRNA gene sequencing (Fig. 1a) was used
to investigate the proportion of the microbiota that was
readily cultured from the gastrointestinal tract. Using
66 culture conditions and applying the same 16S rRNA
gene sequencing method to both the cultured community
and the fecal samples, we demonstrate that the majority of
OTUs could be detected through culture-enriched mo-
lecular profiling and culture detected greater diversity
than culture-independent methods. Culture-enriched mo-
lecular profiling was further applied to the targeted cultur-
ing of Lachnospiraceae isolates.
Methods
Sample collection
This study was approved by the Hamilton Integrated
Research Ethics Board and donors provided consent
prior to participation. Healthy volunteers (HV1–7) had
no gastrointestinal (GI) symptoms and did not use anti-
biotics within 6 months of the study. Irritable bowel
syndrome (IBS) patients (IBS1–4) were diagnosed as
diarrhea-predominant or mixed subtype based on Rome
III criteria [13] and recruited from the GI Clinical In-
vestigation Unit at McMaster University.
Fresh fecal samples were transferred to sterile specimen
containers immediately following defecation and stored in
airtight bags containing an anaerobic pouch (Oxoid, UK)
and ice-pack until transfer to an anaerobic chamber (5 %
CO2, 5 % H2, 90 % N2; Shel Labs, Cornelius, OR, USA),
which occurred within 1–5 h of collection. Afterwards, all
work was completed inside an anaerobic chamber. Sam-
ples were mechanically mixed with a sterile spatula and
cultured as described below.
Culturing of fecal samples
Inside an anaerobic chamber, 0.1 g of fecal sample was
diluted in 900 μl of pre-reduced brain heart infusion
(BHI) broth (BD, Sparks, MD, USA) with 0.05 % L-cyst-
eine hydrochloride hydrate (100 dilution). We plated
100 μl of 10−3 and 10−5 dilutions on pre-reduced 100-
mm agar plates (media types listed below). One set of
media was incubated at 37 °C for 5 days in an anaerobic
chamber and another set was incubated at 37 °C in 5 %
CO2 for 3 days. After incubation, colonies were collected
from each plate by adding 1 ml BHI broth and scraping
the surface of plates with a cell scraper. Both dilutions
(10−3 and 10−5) of each media were combined and
500 μl of the harvested colonies was frozen in 10 % skim
milk at −80 °C as stocks and 500 μl was used for DNA
extraction as described below.
Media used in this study included (Additional file 1:
Table S1): brain heart infusion (BHI) agar (BD), BHI +
0.5 g/L L-cysteine hydrochloride hydrate, 10 mg/L hemin,
and 1 mg/L vitamin K (supplement set A), BHI + 10 mg/L
colistin sulphate and 5 mg/L naladixic acid (supplement
set B), BHI + supplement set A and B, BHI + supplement
set A and 20 mg/L gentamycin, BHI + supplement set A
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and 1 % propionic acid, 0.2× BHI or M9 minimal media
(BD) + one of 1 g/L inulin, 0.5 g/L pectin, 0.5 g/L cellulose,
0.5 g/L mucin, or 0.5 g/L starch, Bifidobacterium Selective
Media (Fluka, St. Louis, MO, USA), Gut Microbiota
Medium [10], phenylethyl alcohol agar (BD) + 5 % sheep’s
blood (Cedarlane, Canada), Bacteroides Bile Esculin agar
[14], Actinomyces Isolation agar (BD), Columbia blood
agar (BD) + 5 % sheep’s blood, colistin naladixic agar (BD)
+ 5 % sheep’s blood, McKay agar [15], chocolate agar
(BD), tryptic soy agar (BD) + 5 g/L yeast extract (BD) +
supplement set A, fastidious anaerobe agar (Neogen,
Lansing, MI, USA), deoxycholate agar [14], MacConkey
agar (BD), kanamycin vancomycin laked blood agar [14],
mannitol salt agar (BD), de Man Rogosa Sharpe agar (BD),
and cooked meat broth (Fluka) + 1.2 % agar. All media
were prepared following the manufacturer’s instructions
or as previously described unless otherwise mentioned.
For experiments showing that cultured communities
were represented by viable organisms (Additional file 2:
Figure S4), 100 mg of frozen IBS1 sample was diluted
1:10 with 70 % isopropanol and heated to 70 °C for
1 min to sterilize (“no-growth” samples) or DNA ex-
tracted from IBS1 sample was used (DNA samples).
The samples were diluted to 10−5 with BHI with 0.05 % L-
cysteine as described above and cultured anaerobically on
phenylethyl alcohol agar (PEA) and M9 + cellulose plates
for 1 h at 37 °C before plates were scraped and DNA was
extracted as described below.
For the comparison of fresh and frozen samples, one
aliquot was immediately cultured and another was
Fig. 1 Culture-enriched molecular profiling captures the majority of OTUs. a The culture-enriched molecular profiling protocol. Fecal samples
were cultured using 66 conditions and colonies were harvested from each plate. 16S rRNA gene sequencing of DNA extracted from colonies
was compared with sequencing of the fecal sample. b OTUs from 16S rRNA gene sequencing of culture-enriched fecal samples were compared with
those from culture-independent sequencing. The number of reads in the culture-independent sequencing of each sample is below the x-axis.
The average proportion of OTUs cultured from each sample is shown; error bars represent standard deviation. c All OTUs from culture-independent
sequencing of HV1 and HV2 samples were ranked by abundance and compared with OTUs detected by culture-enriched sequencing. Each
point represents one OTU and the dashed line indicates 0.1 % relative abundance in the culture-independent sequencing. HV healthy volunteer, IBS
irritable bowel syndrome
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stored at −80 °C for up to one year (IBS1 and HV2 for
4 months, IBS3 for 1 year). To compare anaerobic and
aerobic samples, fecal samples were divided during col-
lection; one portion was stored with an anaerobic pouch
at 4 °C until culturing and the other was stored at 4 °C
without an anaerobic pouch (aerobic sample).
DNA extraction and 16S rRNA gene sequencing
DNA extraction and purification were performed as
previously described [16]. Briefly, 500 μl of harvested
colonies or 0.1 g of fecal sample was mechanically ho-
mogenized with 0.2 g of 0.1 mm glass beads (MoBio,
Carlsbad, CA, USA; an additional 0.2 g of 2.8 mm glass
beads was added to fecal samples) in 800 μl of 200 mM
NaPO4, pH 8 and 100 μl guanidine thiocyanate-EDTA-
N-lauroyl sarcosine. Enzymatic lysis with 50 μl lyso-
zyme (100 mg/ml), 50 μl mutanolysin (10 U/μl), and
10 μl RNase A (10 mg/ml) for 1 h at 37 °C was followed
by the addition of 25 μl 25 % sodium dodecyl sulfate
(SDS), 25 μl Proteinase K (20 mg/ml,) and 75 μl 5 M
NaCl and further incubated for 1 h at 65 °C. Superna-
tants were collected and DNA extracted with phenol-
chloroform-isoamyl alcohol (25:24:1; Sigma, St. Louis,
MO, USA) and further purified using DNA Clean and
Concentrator-25 columns (Zymo, Irvine, CA, USA) as
per the manufacturer’s instructions. Isolated DNA was
stored at −20 °C.
PCR amplification of the V3 region of the 16S rRNA
gene was performed as previously described [17] with
the following modifications: a 60 μl reaction containing
1.25 mM MgCl2, 2.5 mM of each dNTP, 100 nM of
each barcoded primer, and 1.25 U Taq was divided into
3 × 20 μl reactions for amplification. PCR conditions
consisted of an initial denaturation at 94 °C for 2 min,
30 cycles of 94 °C for 30 s, 50 °C for 30 s, 72 °C for
30 s, followed by a final elongation at 72 °C for 10 min.
Purified PCR products were sequenced using the Illu-
mina MiSeq platform by the McMaster Genome Facil-
ity (Hamilton, ON, Canada).
Sequence processing and analysis
16S rRNA gene sequence processing was completed as
previously described [16]. In brief, Illumina sequence
reads were trimmed to the forward and reverse primers
of the V3 region with Cutadapt [18] and paired-end se-
quences were aligned with PANDAseq [19]. OTUs were
binned at 97 % similarity using AbundantOTU [20] and
taxonomy was assigned using the Ribosomal Database
Project (RDP) classifier [21] against the Greengenes ref-
erence database (4 February 2011 release) [22] using
Quantitative Insights Into Microbial Ecology (QIIME)
[23]. Unassigned OTUs and singletons were not in-
cluded. The total number of reads for the culture-
enrichment experiment was 30,581,472. For analysis of
the culture-enriched experiments, only OTUs with at
least ten sequence reads were included and considered
cultured since the number of reads between replicates
was less reproducible below this depth (data not shown).
Relative abundance taxonomic summaries, beta diver-
sity, and rarefactions were completed with QIIME. The
16S rRNA gene phylogeny depicting OTUs from culture-
independent, culture-enriched, or both methods (Fig. 2b)
was created by pruning the 4 February 2011 release of the
Greengenes phylogeny clustered to 97 % similarity. This
phylogeny was pruned using QIIME and visualized using
GraPhlAn v0.9.7 [24].
Lachnospiraceae isolation and identification
Freshly collected HV7 and IBS4 fecal samples were cul-
tured anaerobically on BHI + 1 g/L inulin (BHI + inu)
and cooked meat agar (BEEF). We streaked 146 colonies
for purity and single colonies were boiled in 5 % Chelex
for 15 min to lyse cells. Colony PCR to amplify the 16S
rRNA gene was performed using 8f (5′-AGAGTTT-
GATCCTGGCTCAG-3′) and 927r (5′-CCGTCAATTC
CTTTRAGTTT-3′) primers. PCR conditions consisted
of an initial denaturation at 94 °C for 2 min, 32 cycles of
94 °C for 1 min, 56 °C for 1 min, 72 °C for 2 min,
followed by a final elongation at 72 °C for 10 min. PCR
products were Sanger sequenced by Beckman Coulter
Genomics (Danvers, MA) using the 8f primer. Taxonomic
assignment of isolates was made with the online RDP
Classifier [21] using 16S rRNA training set 10 with a con-
fidence threshold of 80 %. 16S rRNA gene sequences of
the isolates were compared against the Lachnospiraceae
consensus sequences from the Human Microbiome
Project’s (HMP) “Most Wanted” list (obtained on 18
November 2014) using Megablast in Geneious v5.6.4 [25].
Lachnospiraceae phylogeny
The 16S rRNA sequence of 107 Lachnospiraceae type
isolates obtained from RDP [21] (on 12 November
2014) were aligned using MUSCLE v3.8.31 [26] (Edgar,
2004). jModelTest v2.1.1 [27] was used to determine
that the data most appropriately fit the generalized
time-reversible (GTR) model with invariable sites and a
discrete gamma distribution. A maximum likelihood
molecular phylogeny of these isolates was obtained
using raxmlGUI v1.3.1 [28] implementing RAxML
v8.0.26 [29] with 100 bootstrap replicates. pplacer v1.1
[30] was used to add the 16S rRNA gene sequences of
79 cultured Lachnospiraceae isolates, obtained as de-
scribed above. The resulting phylogeny was visualized
and midpoint rooted using FigTree v1.4.0 [31].
Results
In this study, the cultivable proportion of the human gut
microbiota was determined from the fecal samples of
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two healthy donors and three patients with irritable
bowel syndrome (IBS). IBS samples were included since
the culturable bacterial community may be affected by
health status and IBS is a common intestinal disorder in
which the microbial composition of the gut is altered
and implicated in the pathogenesis of the disorder [32].
Using a method of culture-enriched molecular profiling
[12], anaerobic fecal samples were cultured using 33
media and incubation of plates anaerobically and aerob-
ically resulted in 66 culture conditions (Fig. 1a). The
media used were comprised of commercially available
components, without the requirement of complex addi-
tions like rumen fluid or fecal extracts used in previous
studies [8, 33], and were chosen based on previous
culture-enriched molecular profiling studies, with add-
itional media added for specific cultivation of the gut
microbiota, including Bacteroides Bile Esculin, Bifido-
bacterium Selective media, Gut Microbiota medium
[10], and the addition of prebiotics and resistant carbo-
hydrates [33] (Additional file 1: Table S1). The cultivable
portion of the fecal microbiota was determined by pool-
ing all colonies from each type of media (per fecal sam-
ple) and performing 16S rRNA gene sequencing on each
plate pool individually, referred to as culture-enriched
molecular profiling. A portion of the pooled colonies
was reserved for future bacterial isolation. Since the
Fig. 2 Culture-enriched molecular profiling detects more OTUs than culture-independent sequencing. a A comparison of the number of OTUs
detected by culture-independent and culture-enriched sequencing for each fecal sample. The average number of OTUs detected by each method
is shown; error bars represent standard deviation. b Phylogeny of Greengenes 16S rRNA gene sequences to which OTUs were assigned (clustered
to 97 % sequence similarity). The branch nodes and three innermost rings are labeled based on detection by culture-independent, culture-enriched, or
both methods. The outer ring and background are colored by phyla, as indicated in the legend
Lau et al. Genome Medicine  (2016) 8:72 Page 5 of 10
same DNA extraction and sequencing methods were
used for both the cultured plate pools and the fecal sample,
the OTUs from the culture could be directly compared
with the OTUs from culture-independent sequencing of
the original fecal sample to determine which OTUs were
cultured on each type of medium.
Culture-enriched molecular profiling detects the majority
of OTUs in fecal samples
An average of 76 % of all OTUs observed in culture-
independent sequencing of the fecal samples was also
detected by culture-enrichment (Fig. 1b). The largest
proportion of OTUs cultured was 93 % from the
healthy volunteer 1 (HV1) sample. No obvious differ-
ences were observed in the proportions of OTUs cul-
tured between IBS and healthy samples (an average of
79 and 73 % of all OTUs were cultured, respectively).
Using thresholds of 0.01 and 0.1 % (in the culture-
independent sequencing), an average of 81 and 95 % of
OTUs were cultured, respectively (Fig. 1b), indicating
that culture-enriched molecular profiling could detect
the majority of the abundant members of the fecal
community. A comparison of several OTU picking
methods, including AbundantOTU [20] and UCLUST
[34] against different reference databases, resulted in
similar proportions cultured for each sample, indicating
that these results were robust to the method of OTU
clustering (Additional file 2: Figure S1). However, the
proportion of OTUs cultured was affected by culture-
independent sequence depth; as the number of culture-
independent sequence reads increased, the percent of
OTUs cultured decreased (Additional file 2: Figure S2).
Shallow sequencing depth (< 5000 reads) in culture-
independent sequencing, as used in previous studies [10],
would artificially inflate the proportion of the cultured
microbiota due to incomplete culture-independent sam-
pling of fecal samples. For each sample, ranking the OTUs
from culture-independent sequencing by abundance re-
veals a few highly abundant OTUs and a long tail distribu-
tion of lesser abundant OTUs, as expected in human gut
microbiota communities [35] (Fig. 1c; Additional file 2:
Figure S3). Above 0.1 % relative abundance, all OTUs
from HV1 were recovered by culture and only five OTUs
from HV2 were not cultured (Fig. 1c). Uncultured
OTUs were of low abundance (< 0.8 % relative abun-
dance) in the culture-independent sequencing. Twelve
OTUs with relative abundances greater that 0.1 % were
not cultured from the donor samples and included
Cyanobacteria, Clostridia, Mollicutes, and Bacteroi-
detes. However, 9 of these 12 OTUs were detected by
culture in the other fecal samples.
Several bacterial genera were present at less than 1 %
abundance in culture-independent sequencing but recov-
ered by culture at higher abundances on plates (Additional
file 2: Figures S4e and S5), thus demonstrating the advan-
tages of culture for recovering low abundance bacteria
from the GI microbiota. Comparison of each plate com-
munity to the culture-independent fecal samples showed
that no single medium accurately represented the com-
position of the fecal sample, indicating that OTUs de-
tected by culture represent viable organisms and not DNA
deposited on plates (Additional file 2: Figure S4a–d). To
further demonstrate this, a sterilized fecal sample from
the IBS1 donor and DNA extracted from the same sample
were plated on two media, representing cultured commu-
nities most similar and most different to the composition
of the fecal sample (Additional file 2: Figure S4b–d). The
composition of the no-growth and DNA controls were
very different from either the fecal sample or the pooled
plate. Indeed, the negative growth controls from both
types of media were most similar to each other, providing
evidence that 16S sequencing of plates represent growth
of viable cells and not DNA or dead cells deposited from
the fecal sample. Goodman et al. [10] have previously
shown that sequencing of pooled colonies cultured from a
fecal sample diluted 10,000-fold resulted in less than 2 %
of the sequences being derived from non-viable cells.
The minimal conditions for culture-enrichment reflects
the inter-individual heterogeneity of the human gut
microbiota
The cultured communities on each media differed be-
tween samples, reflecting the inter-individual heterogen-
eity of the microbiota [3]; thus, a minimal set of media
that could capture the majority of OTUs in all samples
would be difficult to predict, similar to results previously
reported for the airway microbiome [12]. By determining
the minimum culture conditions needed to recover all
culturable OTUs present at greater than 0.1 % in the
fecal samples, we observed that the set of culture condi-
tions required was different for all five fecal samples
(Additional file 2: Figure S6). Interestingly, 23 of the 33
anaerobic culture conditions were required across the
five samples, indicating that most of the media used
were non-redundant, and additional fecal samples may
necessitate the use of the other media. There was a dis-
tinct difference in the bacterial communities recovered
from anaerobic incubation compared with aerobic
growth (Additional file 2: Figure S5); Escherichia was the
most abundant OTU on the majority of aerobic media
used so future studies could reduce the number of aer-
obic conditions.
The cultured community is affected by storage conditions
of the fecal sample
Since immediate culturing of anaerobic fecal samples
may not always be feasible, we determined the affect of
freezing at −80 °C or exposure to ambient oxygen on
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the culturable fecal community. Fresh, anaerobic fecal
samples were cultured as done previously and the
culture-enriched profiles were compared with those
from fecal samples that were frozen or exposed to oxy-
gen (Additional file 2: Figure S7a–e). All conditions
tested showed that the cultured microbiome profile was
different after freezing, with Bray–Curtis dissimilarity dis-
tances greater than 0.3 (Additional file 2: Figure S7a, d),
while fecal samples were differentially affected by aerobic
exposure, with Bray–Curtis dissimilarity distance ranging
from 0.15 to 0.65 (Additional file 2: Figure S7b, c, e). Since
the compositions of the fecal samples were different from
each other and each medium used selected for different
bacteria, no abundant bacterial groups were identified as
consistently altered after storage. Optimal recovery of
bacteria required stool samples to be kept anaerobic
immediately after collection and plated without freez-
ing, as exposure to oxygen and storage at −80 °C al-
tered the culturable community.
Culture-enriched molecular profiling captures greater
bacterial diversity than culture-independent sequencing
Importantly, we observed that culture-enrichment re-
covered more OTUs than culture-independent sequen-
cing. Taking into account all OTUs detected in the five
samples by both methods, 1051 OTUs (67 % of the
total) were detected only by culture-enrichment, 390
OTUs (25 %) were found by both methods, and 118
OTUs (8 %) were detected only by culture-independent
sequencing. For each sample, more OTUs were ob-
served by culture-enriched sequencing than culture-
independent sequencing (Fig. 2a). This suggests that
even with deep sequencing of a fecal sample (average
depth = 206 076 reads), culture detects greater bacterial
diversity compared with culture-independent methods.
The OTUs that were detected only by culture were
mainly distributed across six phyla: Actinobacteria,
Bacteroidetes, Firmicutes, Fusobacteria, Proteobacteria,
and Tenericutes. These low abundance organisms may
include bacteria from the colonic mucosa and other
sites in the GI tract, where they may be present at
higher local abundance but at too low abundance in
stool to be detected by the culture-independent se-
quencing depths used in this study. OTUs that were
culture-only or detected by both methods were evenly
distributed across the bacterial taxonomy (Fig. 2b), in-
dicating that cultured OTUs represent members of the
fecal microbiota and not plate contamination. Uncul-
tured OTUs included a Tenericutes branch and a few
Firmicutes clades.
Targeted culturing of Lachnospiraceae isolates
Culture-enriched molecular profiling was applied to add-
itional healthy (HV3) and IBS (IBS4) fecal samples for
the targeted culturing of Lachnospiraceae isolates to
demonstrate that a bacterial group of interest could be
isolated from fecal samples, when the bacterial compos-
ition was not known, by using results of culture-
enriched profiling of previous samples (Additional file 2:
Figure S5). There is extensive Lachnospiraceae diversity
in the human gut microbiota but this prevalent and
abundant family is poorly represented by reference ge-
nomes [36]. From analysis of the culture-enriched profil-
ing of previous fecal samples, it was determined that
communities grown on anaerobic BHI + inu and BEEF
agar were dominated by Lachnospiraceae (Additional
file 2: Figure S5). Consistent with our culture-enrichment
results, inulin has been shown to increase growth of
butyrate-producing bacteria, including Lachnospiraceae,
both in vivo [37] and in vitro [38]. HV3 and IBS4 fecal
samples were cultured anaerobically on BHI + inu and
BEEF and colonies were isolated (as opposed to plate
pooling). Sanger sequencing of the 16S rRNA gene of 146
isolated colonies resulted in the identification of 79 Lach-
nospiraceae isolates, including representatives of the
genera Blautia, Marvinbryantia, Ruminococcus, Dorea,
Eubacterium, Anaerostipes, Clostridium, and Coprococcus
(Additional file 3: Table S2). Additionally, 18 isolates had
less than 97 % similarity to Ribosomal Database Project
(RDP) reference isolates at the genus level [21], as sup-
ported by the phylogenetic distance of these isolates to the
107 RDP Lachnospiraceae reference sequences (Fig. 3).
These 18 isolates may be novel species not currently rep-
resented by the RDP type isolates. Comparison of the 16S
rRNA gene sequences of the Lachnospiraceae isolates to
the Human Microbiome Project’s (HMP) Most Wanted
taxa resulted in a match to 12 sequences with 100 %
identity, including four organisms of medium priority
(Additional file 4: Table S3). The “Most Wanted” taxa rep-
resent uncultured but abundant and prevalent organisms
from the HMP 16S rRNA gene sequencing data set [39].
Isolation of novel representatives of the gut microbiome
and whole genome sequencing of these organisms will
add critical information to reference genome collections
and lead to more accurate assignments for metagenomics,
transcriptomics, and proteomic studies.
Discussion
Although other studies have attempted to culture the
gut microbiota using complicated methods such as che-
mostats [40] and microfluidic devices [41], we show that
the use of extensive culture conditions and simple agar
plates results in the comprehensive cultivation of bac-
teria from the gut microbiota. Using significantly fewer
and less complex culture conditions than Lagier et al.
[8], we were still able to capture the majority of OTUs
seen by culture-independent sequencing. Indeed, we be-
lieve that this is the first study showing that > 50 % of
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the OTUs from a fecal sample can be recovered by cul-
ture. We also show that culture revealed greater bacterial
diversity than detected by culture-independent sequen-
cing. These organisms, absent or underrepresented in
culture-independent profiling, may contribute to host
phenotypes so methods to detect and isolate this popula-
tion are critical for future studies. We did not observe a
difference in the proportion of OTUs that could be cul-
tured between IBS and healthy fecal samples; however,
our sample size was small and further studies should be
carried out to confirm this. By applying the data generated
from culture-enriched molecular profiling in the first part
of this study, we were able to carry out the targeted isola-
tion of Lachnospiraceae. This resulted in the recovery of
up to 18 species not represented by a reference database
from culturing only two fecal samples on two media con-
ditions, demonstrating that culture is valuable for acces-
sing novel members of the gut microbiota.
Although most fecal OTUs were cultured in this study,
some OTUs likely contained more than one strain and
some strains may have been missed by culture; metage-
nomics may sort this out. Some OTUs were detected only
Fig. 3 16S rRNA maximum-likelihood tree of 79 Lachnospiraceae isolates in relation to 107 RDP Lachnospiraceae type isolates. V1–V4 16S
rRNA gene sequences of cultured Lachnospiraceae isolates were placed into a phylogeny created with RDP Lachnospiraceae type isolates.
Blue represents cultured isolates; red represents cultured isolates with < 97 % similarity to RDP reference isolates. Branch labels show bootstrap values.
Branch colors highlight clades for visual aid. C Clostridium, B Butyrivibrio, E Eubacterium
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by culture-enrichment or culture-independent sequen-
cing, suggesting that both methods are complementary for
studying the gut microbiota since the combination is more
sensitive than either method alone. The uncultured OTUs
may have been missed due to the following reasons: sto-
chastic sampling if the bacteria were rare in the sample,
DNA could have originated from dead cells, slower grow-
ing organisms may have been out-competed by less fas-
tidious members of the community, or the media used in
this study may have been missing a nutrient required for
growth or prevented growth of a bacterial partner critical
for survival. This may also explain why some OTUs were
not detected by culturing in one fecal sample but recov-
ered from another donor.
Consistent with previous studies [8, 11], we observed
many OTUs that were only detected by culture. Certain
bacterial groups may be under-represented by primers
used in 16S sequencing of complex communities, such
as stool, since poor primer alignment would result in
these sequences being outcompeted during PCR of
mixed community DNA [36]. However, these bacteria
can be grown using selective media and subsequently
detected by culture-enriched molecular profiling since
there may be less competing DNA in 16S rDNA ampli-
fication of the plate pools. As previously reported, bac-
teria present at < 106 cells per gram of feces is likely to
be missed by sequencing depths used in most micro-
biome studies [8], but the ability to grow less abundant
bacteria on media would increase recovery of DNA for
sequencing these rarer members of the population.
Additionally, DNA from bacterial spores in stool may
be underrepresented by 16S sequencing, depending on
the method of DNA extraction [42], but germination of
spores during culture would allow for increased detec-
tion of spore-forming populations.
Culture-enriched molecular profiling for the targeted
recovery of specific bacterial groups will be a powerful
tool for the study of the gut microbiota since bacteria
of interest could be recovered after sequencing has re-
vealed which media support its growth, as represented
in Additional file 2: Figure S5. Furthermore, since this
method allows for the development of a bacterial com-
munity on a plate, it does not exclude syntrophic inter-
actions that may be required for growth of some
bacteria [43]. In addition, subsequent culturing of plate
pools using combinations of antibiotics and other se-
lective media components can be used to develop more
refined culture conditions for specific bacteria [11]. The
application of this method for the recovery of novel
representatives of the gut microbiota will add to reference
databases and lead to more accurate assignment for future
“omic” studies. To advance the microbiome field beyond
correlative investigations and to test hypotheses generated
from culture-independent studies, it is critical to isolate
bacteria of interest from the gut microbiota and culture-
enriched molecular profiling allows for such isolation.
Conclusions
We demonstrate that the majority of the human gut
microbiota can be captured by culture-enriched profiling
and this method can be applied to the recovery of specific
bacterial groups. This method also highlights the ability of
culture for recovering low abundance bacteria and for re-
vealing diversity that may be underrepresented by other
methods. Isolation of bacteria will allow us to explore the
therapeutic potential of bacterial products which may dir-
ectly affect the host or microbial community. Access to
the cultured human microbiota will offer detailed func-
tional characterization of bacteria and will facilitate the
discovery of their biological activities during host–bacteria
and inter-bacterial interactions in health and disease.
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